IRIS

Infection Risk With Biologic Therapy in Patients With Inflammatory Bowel Disease / Hindryckx, P., Novak, G., Bonovas, S., Peyrin-Biroulet, L., Danese, S.. - In: CLINICAL PHARMACOLOGY & THERAPEUTICS. - ISSN 0009-9236. - 102:4(2017), pp. 633-641. [10.1002/cpt.791]

Infection Risk With Biologic Therapy in Patients With Inflammatory Bowel Disease

Danese S
2017-01-01
2017
102
4
633
641
9
2-s2.0-85029359748
WOS:000410302100023
Infection Risk With Biologic Therapy in Patients With Inflammatory Bowel Disease / Hindryckx, P., Novak, G., Bonovas, S., Peyrin-Biroulet, L., Danese, S.. - In: CLINICAL PHARMACOLOGY & THERAPEUTICS. - ISSN 0009-9236. - 102:4(2017), pp. 633-641. [10.1002/cpt.791]
none
5
info:eu-repo/semantics/article
262
Hindryckx, P; Novak, G; Bonovas, S; Peyrin-Biroulet, L; Danese, S
1 Contributo su Rivista::1.1 Articolo in rivista
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/119819
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 34
  • ???jsp.display-item.citation.isi??? 30
social impact